Article
T cell therapy in combination with Vemurafenib in BRAF mutated metastatic melanoma patients
Journal for ImmunoTherapy of Cancer,
BMJ,
ISSN 2051-1426
Volume 2,
Suppl 3,
2014
DOI:10.1186/2051-1426-2-s3-p67,
Dimensions: pub.1028325160,
PMC: PMC4288719,
Authors
* Corresponding author
Affiliations
Organisations
- (1) Center for Cancer Immunotherapy, Herlev, Denmark
- (2) Herlev Hospital, grid.411900.d, Capital Region